Bombay Super Hybrid Seeds re-appoints Richa Kaushal Mashru as Independent Director
- Richa Kaushal Mashru re-appointed as Independent Director for a second five-year term
- New term effective from October 1, 2026, to September 30, 2031
- Approval granted by shareholders at AGM held on September 30, 2026
- Director has no familial relationship with other board members

*this image is generated using AI for illustrative purposes only.
Bombay Super Hybrid Seeds Limited re-appointed Richa Kaushal Mashru as an Independent Director for a second term of five years, effective October 1, 2026. The decision was approved by shareholders at the company's Annual General Meeting held on September 30, 2026.
Governance update details
The appointment follows the recommendation of the Nomination and Remuneration Committee and the Board of Directors. The new term will run until September 30, 2031. This disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Director profile and compliance
Mashru brings expertise in financial and investment management, along with leadership traits and diverse business experience. The company confirmed that she is not related to any other directors of Bombay Super Hybrid Seeds. Furthermore, she is not debarred from holding the office of director by any regulatory authority.
| Detail | Information |
|---|---|
| Director Name | Richa Kaushal Mashru |
| Role | Non-Executive Independent Director |
| Term Start | October 1, 2026 |
| Term End | September 30, 2031 |
| Duration | 5 years |
The Annual General Meeting commenced at 2:00 pm and concluded at 2:37 pm on September 30, 2026.
Historical Stock Returns for Bombay Super Hybrid Seeds
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.23% | +0.54% | -6.26% | +27.80% | -33.04% | +196.90% |
How might Mashru's financial management expertise influence Bombay Super Hybrid Seeds' upcoming capital allocation or M&A strategies?
Will the re-appointment of an independent director with investment backgrounds signal a shift in the company's approach to investor relations or ESG governance?
What specific regulatory or market risks is the board aiming to mitigate through this continuity in independent oversight?

































